CompletedNCT06500624
Escitalopram alone or with pizotifen for depression
About this title
Read the official source — NCT06500624Medication studyAges 18–70Pakistan
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- RawalpindiSee all locations and recruitment
Study information
Study start dateStarted: June 3, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 88
- Sponsor
- Riphah International University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- Pakistan
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT06500624
- Official title
Show the full official title
Comparative Efficacy of Escitalopram Monotherapy and Escitalopram in Adjuvant With Pizotifen in Depressive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Rawalpindi
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Riphah International University, a university.
Did this study involve medication?
Yes. The study involved medication, including Pizotifen.
Who was this study for?
Listed age limits: 18 years to 70 years.
